Brinck T, Handolin L, Lefering R
Töölö Trauma Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Töölö Trauma Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Scand J Surg. 2016 Jun;105(2):109-16. doi: 10.1177/1457496915586650. Epub 2015 May 19.
Fluid resuscitation of severely injured patients has shifted over the last decade toward less crystalloids and more blood products. Helsinki University trauma center implemented the massive transfusion protocol in the end of 2009. The aim of the study was to review the changes in fluid resuscitation and its influence on outcome of severely injured patients with hemodynamic compromise treated at the single tertiary trauma center.
Data on severely injured patients (New Injury Severity Score > 15) from Helsinki University Hospital trauma center's trauma registry was reviewed over 2006-2013. The isolated head-injury patients, patients without hemodynamic compromise on admission (systolic blood pressure > 90 or base excess > -5.0), and those transferred in from another hospital were excluded. The primary outcome measure was 30-day in-hospital mortality. The study period was divided into three phases: 2006-2008 (pre-protocol, 146 patients), 2009-2010 (the implementation of massive transfusion protocol, 85 patients), and 2011-2013 (post massive transfusion protocol, 121 patients). Expected mortality was calculated using the Revised Injury Severity Classification score II. The Standardized Mortality Ratio, as well as the amounts of crystalloids, colloids, and blood products (red blood cells, fresh frozen plasma, platelets) administered prehospital and in the emergency room were compared.
Of the 354 patients that were included, Standardized Mortality Ratio values decreased (indicating better survival) during the study period from 0.97 (pre-protocol), 0.87 (the implementation of massive transfusion protocol), to 0.79 (post massive transfusion protocol). The amount of crystalloids used in the emergency room decreased from 3870 mL (pre-protocol), 2390 mL (the implementation of massive transfusion protocol), to 2340 mL (post massive transfusion protocol). In these patients, the blood products' (red blood cells, fresh frozen plasma, and platelets together) relation to crystalloids increased from 0.36, 0.70, to 0.74, respectively, in three phases.
During the study period, no other major changes in the protocols on treatment of severely injured patients were implemented. The overall awareness of damage control fluid resuscitation and introduction of massive transfusion protocol in a trauma center has a significant positive effect on the outcome of severely injured patients.
在过去十年中,重症创伤患者的液体复苏方式已逐渐从更多使用晶体液转向更多使用血液制品。赫尔辛基大学创伤中心于2009年底实施了大量输血方案。本研究的目的是回顾在单一三级创伤中心接受治疗的血流动力学不稳定的重症创伤患者的液体复苏变化及其对治疗结果的影响。
回顾了赫尔辛基大学医院创伤中心创伤登记处2006 - 2013年期间重症创伤患者(新损伤严重程度评分>15)的数据。排除单纯头部损伤患者、入院时无血流动力学不稳定(收缩压>90或碱剩余> -5.0)的患者以及从其他医院转入的患者。主要结局指标为30天住院死亡率。研究期分为三个阶段:2006 - 2008年(方案实施前,146例患者)、2009 - 2010年(大量输血方案实施阶段,85例患者)和2011 - 2013年(大量输血方案实施后,121例患者)。使用修订的损伤严重程度分类评分II计算预期死亡率。比较标准化死亡率以及院前和急诊室给予的晶体液、胶体液和血液制品(红细胞、新鲜冰冻血浆、血小板)的量。
纳入的354例患者中,标准化死亡率在研究期间从0.97(方案实施前)、0.87(大量输血方案实施阶段)降至0.79(大量输血方案实施后)(表明生存率提高)。急诊室使用的晶体液量从3870 mL(方案实施前)、2390 mL(大量输血方案实施阶段)降至2340 mL(大量输血方案实施后)。在这些患者中,三个阶段血液制品(红细胞、新鲜冰冻血浆和血小板总量)与晶体液的比例分别从0.36、0.70增至0.74。
在研究期间,重症创伤患者治疗方案未实施其他重大改变。创伤中心对损伤控制液体复苏的总体认识以及大量输血方案的引入对重症创伤患者的治疗结果有显著的积极影响。